Skip to main content
Jinyu Bio-Technology Co.,Ltd. logo

Jinyu Bio-Technology Co.,Ltd. — Investor Relations & Filings

Ticker · 600201 ISIN · CNE000000Y37 Shanghai Stock Exchange Manufacturing
Open in API
Filings indexed 1,777 across all filing types
Latest filing 2020-08-14 Governance Information
Country CN China
Listing Shanghai Stock Exchange 600201

About Jinyu Bio-Technology Co.,Ltd.

http://jinyubiotech.com/

Jinyu Bio-Technology Co., Ltd. focuses on the research, development, and manufacturing of veterinary biological products and pharmaceuticals. The company is a prominent supplier of animal vaccines, particularly specializing in Foot-and-Mouth Disease (FMD) vaccines, brucellosis vaccines, and solutions for swine and poultry diseases. It utilizes advanced biotechnology platforms, including large-scale suspension culture and high-efficiency purification processes, to produce high-titer, high-purity biologicals. The organization operates sophisticated research facilities and Biosafety Level 3 (P3) laboratories to support the development of diagnostic reagents and preventive treatments. Its operations center on enhancing animal health through scientific innovation, providing comprehensive disease control strategies for the global livestock industry and large-scale agricultural operations.

Recent filings

Filing Released Lang Actions
关于修订《公司章程》、《股东大会工作条例》和《监事会工作条例》的公告
Governance Information Classification · 95% confidence The document is an announcement from a company about revisions to its Articles of Association, Shareholders' Meeting Rules, and Supervisory Board Rules. It details changes in governance documents and procedures, referencing legal compliance and corporate governance practices. There is no financial data, earnings information, or report publication mentioned. The content focuses on governance structure and internal rules, which aligns with Governance Information filings. The document length is over 6,000 characters and contains detailed governance-related content, not just an announcement of a report publication. Therefore, the appropriate classification is Governance Information (CGR).
2020-08-14 Chinese
独立董事关于公司2020年限制性股票激励计划（草案）及相关事项的独立意见
Governance Information Classification · 95% confidence The document is an independent director's opinion on a 2020 restricted stock incentive plan draft for a company. It discusses compliance with relevant laws and regulations, the qualifications of incentive recipients, and the rationale and fairness of the incentive plan and its performance assessment criteria. There is no financial data, earnings information, or report publication announcement. The content is related to governance and management decisions regarding stock incentive plans, which aligns with governance or management information. However, it is specifically an independent director's opinion on a stock incentive plan, which is a governance-related document rather than a general management report or financial report. It does not fit into categories like Annual Report, Earnings Release, or Capital Update. The best fit is Governance Information (CGR) as it deals with internal governance practices and compliance with regulatory frameworks for stock incentives.
2020-08-14 Chinese
2020年限制性股票激励计划（草案）
Remuneration Information Classification · 95% confidence The document is a detailed plan titled '2020 年限制性股票激励计划 (草案)' which translates to '2020 Restricted Stock Incentive Plan (Draft)' for 金宇生物技术股份有限公司. It extensively describes the stock incentive plan, including legal basis, stock source, number of shares, eligibility, lock-up periods, vesting schedules, performance conditions, and governance related to the stock incentive program. The document is lengthy (15,000 characters) and contains detailed procedural and regulatory information about the stock incentive plan. This type of document is a detailed disclosure about executive and employee remuneration through stock incentives, which fits the category of Remuneration Information filings. It is not an announcement, nor a general regulatory filing, nor a financial report. Therefore, the correct classification is Remuneration Information (DEF 14A).
2020-08-14 Chinese
2020年限制性股票激励计划草案摘要公告
Remuneration Information Classification · 95% confidence The document is a detailed announcement regarding a 2020 restricted stock incentive plan (股权激励计划) for a company, including specifics about stock grants, eligibility, conditions, lock-up periods, performance targets, and legal compliance. It is not a financial report like an annual or quarterly report, nor is it a simple announcement of voting results or a proxy statement. The content focuses on management compensation and stock incentive plans, which aligns with remuneration or compensation disclosures. Given the detailed nature of the stock incentive plan and its focus on executive and employee compensation, the document best fits the category of Remuneration Information (DEF 14A). The document is lengthy and substantive, not a brief announcement or a regulatory filing, so it is not RNS or RPA. Therefore, the classification is DEF 14A with high confidence.
2020-08-14 Chinese
2020年限制性股票激励计划首次授予激励对象名单
Remuneration Information Classification · 95% confidence The document is a detailed list of recipients for a 2020 restricted stock incentive plan, including allocation details and names of core management and technical personnel. It focuses on stock incentive allocations rather than financial results, management changes, or voting outcomes. This type of document is typically related to remuneration or compensation plans for executives and key employees. Given the nature of the content, it aligns best with Remuneration Information filings, which detail compensation plans such as stock incentives.
2020-08-14 Chinese
监事会工作条例（2020年8月修订）
Governance Information Classification · 95% confidence The document is titled as the "Work Rules of the Supervisory Board" of a company, detailing the structure, duties, rights, meeting procedures, and decision-making processes of the supervisory board. It is a governance-related document outlining internal rules and supervisory functions rather than financial results, audit opinions, or announcements. There is no indication of financial data, earnings, voting results, or regulatory filings. The content fits the description of Governance Information (CGR), which covers internal rules, board structure, and governance practices.
2020-08-14 Chinese

Browse filings by year

28 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.